Building Blocks

Versatile small molecule scaffold

Versatile small molecule scaffold

2-(2-Methylphenyl)propan-2-ol is an abiotic chemical that is used as a solvent for ethanol. It has been shown to be toxic to microalgae and fatty acids, by inhibiting the conversion of nitrate into nitrogen gas. 2-(2-Methylphenyl)propan-2-ol has also been shown to inhibit denitrification in the presence of nitrate and carbon sources. The mechanism of inhibition is unknown, but it may be due to the formation of an unidentified aromatic hydrocarbon that prevents nitrite reduction.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

7-Ethylquinoline is a quinoline derivative that has been shown to have potential as an antimalarial drug. 7-Ethylquinoline has been found to be effective against malaria parasites in the laboratory, with many of its derivatives having high yields and low toxicity. The structure of 7-ethylquinoline can be analysed by nuclear magnetic resonance (NMR) spectroscopy, which can also be used to identify the isomers present. 7-Ethylquinoline is a heterocyclic ring that contains a basicity at position 3, with a pKa value of 10.2. This chemical does not contain any contaminants and can be produced using various techniques.

5-Methylquinoline is a quinoline derivative that is used in the synthesis of other quinoline derivatives. It can be synthesized from cinnamaldehyde, which can be obtained from cinnamic acid or benzaldehyde. 5-Methylquinoline has been shown to have antioxidant properties and inhibit colorectal carcinoma cells in vitro. The compound also inhibits the growth of caco-2 cells. One isomer of 5-methylquinoline, ethenyl, has been shown to cause a shift in the spectrum of light absorbed by caco-2 cells.

Versatile small molecule scaffold

Monoethylglycinexylidine (MEGX) is a drug that has been shown to be effective in the treatment of chronic viral hepatitis. It has an activity index of 0.6-2.0 and can be used as a diagnostic tool for hepatic impairment. MEGX has also been found to be more effective in patients with primary sclerosing cholangitis than in those with non-primary sclerosing cholangitis. MEGX inhibits the P450 enzyme, which is involved in the metabolism of xenobiotics and endogenous compounds, and also inhibits Lidocaine-induced bronchoconstriction. The structural analysis of MEGX showed that it forms a stable complex with the active site of P450 enzymes, but does not form stable complexes with other enzymes such as cytochrome P450 reductase or epoxide hydrolase. In vivo experiments have shown that MEGX inhibits liver regeneration in mice by inhibiting hepatocyte

Versatile small molecule scaffold

2-(Thiazol-4-yl)ethanamine is a histamine H1 receptor agonist that is used in tumor models to study the activation of histamine receptors. It has been shown to be an orally active ligand for the histamine H1 receptor. 2-(Thiazol-4-yl)ethanamine binds to the benzyl group, which is present in both histamine and the h1 receptor, and interacts with the imidazole ring of histamine and phenyl ring of the h1 receptor. This drug has physicochemical properties that are similar to those of histamine.

Versatile small molecule scaffold